Clinical Trials Browser

Phase 1/2 × Terminated × veliparib × Clear all

NCT02412371 2020-07-22

A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Terminated

48 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung